Literature DB >> 7192813

Human lymphocyte capping in Duchenne muscular dystrophy.

A L Horenstein, A E Emery.   

Abstract

We have confirmed the observation that, in patients with Duchenne muscular dystrophy, there is a significant reduction in lymphocyte capping. However, our results indicated that this may be related to the degree of muscle damage in these boys, since it was correlated to both age and serum creatine kinase activity and could therefore be a secondary phenomenon.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7192813     DOI： 10.1212/wnl.30.12.1330

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Lymphocyte capping in myotonic dystrophy.

Authors:  G L Walker; U Karagol; E C Mathieson; R J Lane; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

3.  Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.

Authors:  A Sensi; A Venturoli; S Traniello; M Lucci; C Vullo; C Conighi; P L Mattiuz; O R Båricordi
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

4.  A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblasts from patients and carriers.

Authors:  G E Jones; J A Witkowski
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

5.  Impairment of capping in lymphoblastoid cell lines of Duchenne patients indicates an intrinsic cellular defect.

Authors:  O R Baricordi; A Sensi; A Balboni; G Romeo; M Rocchi; L Melchiorri; E Gandini
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

Review 6.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.